A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: unbiased (1), impartial (11), pale (37)

Bevacizumab (15mgkg)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15) This protocol may require funding Regimen Ovary-Bevacizumab (15) Indication Recurrent platinum sensitive ovarian, perito
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg.pdf

Cisplatin-Gemcitabine Ver 2.1

Description
Chemotherapy Protocol PANCREATIC CANCER CISPLATIN-GEMCITABINE (RADIOTHERAPY) Regimen Pancreatic Cancer – Cisplatin-Gemcitabine RT Indication Locally unresectable no
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Cisplatin-GemcitabineVer21.pdf

Panitumumab (14 day) Ver 1.2

Description
Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (14 day) This regimen may require funding Regimen Colorectal Cancer – Panitumumab (14 day) Indication Metastatic colorectal cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab14dayVer12.pdf

Cetuximab (14 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (14 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuximab (14 day) Indication • Metastatic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab14day.pdf

AmB - Cytarabine(1500)

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (1500mg/m2) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only Regimen
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine1500-Ver-1.pdf

AmB - Cytarabine(3000)

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (3000mg/m2) Ambulatory Regimen This regimen is for AMBULATOR
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine-3000.pdf

HSCT Amb Melphalan-Bortezomib SC

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT AMBULATORY MELPHALAN and BORTEZOMIB SC Multiple Myeloma This regimen will only be available to prescri
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCT-Amb-Melphalan-Bortezomib-SC-Ver1.pdf

Nivolumab-Relatlimab

Description
Chemotherapy Protocol SKIN CANCER Nivolumab in combination with Relatlimab (Opdualag) Regimen • Skin – Nivolumab in in combination with Relatlimab (Opdualag) Ind
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Nivolumab-Relatlimab-Ver1.pdf

UHS Patient Hub - frequently asked questions

Description
We’re making things easier for you to manage your appointments online We use the secure online portal Patient Hu
Url
/Media/UHS-website-2019/Docs/For-patients/UHS-Patient-Hub-frequently-asked-questions.pdf

Cyclophosphamide-Epirubicin-Paclitaxel 21day

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-21day.pdf
121 to 130 of 265
Previous … 11 12 13 14 15 … Next